JDLA
GILD icon

J. Derek Lewis & Associates’s Gilead Sciences GILD Stock Holding History

J. Derek Lewis & Associates’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$387K Buy
3,063
+43
+1% +$5.67K 0.07% 125
2026
Q1 		$421K Buy
3,020
+200
+7% +$28K 0.09% 114
2025
Q4 		$346K Buy
+2,820
New +$343K 0.08% 121

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

J. Derek Lewis & Associates's GILD Position: Q2 2026 in Review

J. Derek Lewis & Associates increased its Gilead Sciences (GILD) stake by 1.4% in Q2 2026, buying an estimated $5.67K and bringing the position to 3,063 shares worth $387K. The position accounts for 0.07% of the portfolio, ranked #125.

J. Derek Lewis & Associates first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $421K in Q1 2026. 1,412 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • J. Derek Lewis & Associates held 3,063 shares of Gilead Sciences worth $387K as of Q2 2026.
  • J. Derek Lewis & Associates bought 43 Gilead Sciences shares in Q2 2026, an estimated $5.67K.
  • Gilead Sciences made up 0.07% of J. Derek Lewis & Associates's portfolio in Q2 2026, its #125 holding.
  • J. Derek Lewis & Associates first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • J. Derek Lewis & Associates's Gilead Sciences position peaked at $421K in Q1 2026.
  • 1,412 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on J. Derek Lewis & Associates's 13F filing for Q2 2026, filed 31 Jul 2026.